Attached files

file filename
EX-21.1 - EX-21.1 - IsoPlexis Corpexhibit211-sx1.htm
EX-10.9 - EX-10.9 - IsoPlexis Corpexhibit109-sx1.htm
EX-10.8 - EX-10.8 - IsoPlexis Corpexhibit108-sx1.htm
EX-10.7 - EX-10.7 - IsoPlexis Corpexhibit107-sx1.htm
EX-10.6 - EX-10.6 - IsoPlexis Corpexhibit106-sx1.htm
EX-10.5 - EX-10.5 - IsoPlexis Corpexhibit105-sx1.htm
EX-10.4 - EX-10.4 - IsoPlexis Corpexhibit104-sx1.htm
EX-10.3 - EX-10.3 - IsoPlexis Corpexhibit103-sx1.htm
EX-10.2 - EX-10.2 - IsoPlexis Corpexhibit102-sx1.htm
EX-10.1 - EX-10.1 - IsoPlexis Corpexhibit101-sx1.htm
EX-5.1 - EX-5.1 - IsoPlexis Corpexhibit51-s1.htm
EX-4.3 - EX-4.3 - IsoPlexis Corpexhibit43-sx1.htm
S-1 - S-1 - IsoPlexis Corpisoplexis-sx1.htm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated May 13, 2021, relating to the financial statements of IsoPlexis Corporation. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ Deloitte & Touche LLP
Hartford, Connecticut
July 20, 2021